RENN Fund, Inc. - Quarter Report: 2007 September (Form 10-Q)
UNITED[KM1]
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
________________
Form
10-Q
[X] QUARTERLY
REPORT PURSUANT TO SECTION 13 OR 15(d)
OF
THE SECURITIES EXCHANGE ACT OF 1934
For
the
quarterly period ended September 30, 2007
OR
[
] TRANSITION
REPORT PURSUANT TO SECTION 13 OR 15(d)
OF
THE SECURITIES EXCHANGE ACT OF 1934
For
the
Transition period from ________ to ________ .
Commission
file number: 0-20671
RENAISSANCE
CAPITAL
GROWTH&
INCOME
FUND
III, INC.
(Exact
name of registrant as specified in its charter)
TX
|
75-2533518
|
(State
or other jurisdiction
of
incorporation or organization)
|
(I.R.S.
Employer
Identification
No.)
|
8080
N. Central Expressway, Suite 210, LB-59, Dallas, TX 75206
(Address
of principal executive
offices)
|
(Zip
Code)
|
Registrant’s
telephone number, including area code: 214-891-8294
None
(Former
name, former address and former fiscal year
if
changed since last report)
Indicate
by check mark whether the registrant: (1) has filed all reports required to
be
filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the
preceding 12 months (or for such shorter period that the registrant was required
to file such reports); and (2) has been subject to such filing requirements
for
the past 90 days.
Yes
þ
No
o.
Indicate
by check mark whether the registrant is a large accelerated filer, an
accelerated filer, or a non-accelerated filer. See definition of accelerated
filer and large accelerated filer in Rule12b-2 of the Exchange Act. (Check
one):
Large
accelerated filer o Accelerated
filer o Non-accelerated
filer þ
Indicate
by check mark whether the registrant is a shell company (as defined in Rule
12b-2 of the Exchange Act).
Yes
o
Noþ.
As
of
September
30, 2007,
the
issuer had 4,463,967 shares of common stock outstanding.
RENAISSANCE
CAPITAL GROWTH & INCOME FUND III, INC.
INDEX
Page
|
||
|
Number
|
|
PART
I. FINANCIAL INFORMATION
|
||
Item
1. Financial Statements (Unaudited)
|
||
Statements
of Assets and Liabilities as of September 30, 2007 and December
31,
2006
|
3
|
|
Schedules
of Investments as of September 30, 2007 and December 31,
2006
|
4
|
|
Statements
of Operations for the three months ended September 30, 2007 and
2006
|
14
|
|
Statements
of Operations for the nine months ended September 30, 2007 and
2006
|
15
|
|
Statements
of Change in Net Assets for the nine months ended September 30,
2007 and
2006
|
16
|
|
Statements
of Cash Flows for the nine months ended September 30, 2007 and
2006
|
17
|
|
Notes
to Financial Statements
|
18
|
|
Item
2. Management’s Discussion and Analysis of Financial Condition and Results
of Operations
|
24
|
|
Item
3. Quantitative and Qualitative Disclosures About Market
Risk
|
26
|
|
Item
4. Controls and Procedures
|
27
|
|
PART
II. OTHER INFORMATION
|
||
Item
1. Legal Proceedings
|
28
|
|
Item
1A. Risk Factors
|
28
|
|
Item
2. Unregistered Sales of Equity Securities and Use of
Proceeds
|
30
|
|
Item
3. Defaults Upon Senior Securities
|
30
|
|
Item
4. Submission of Matters to a Vote of Security
Holders
|
30
|
|
Item
5. Other Information
|
30
|
|
Item
6. Exhibits
|
30
|
|
Signatures
|
31
|
PART
I - FINANCIAL INFORMATION
ITEM
1.
FINANCIAL STATEMENTS
Renaissance
Capital Growth & Income Fund III, Inc.
Statements
of Assets and Liabilities
(Unaudited)
September
30, 2007
|
|
December
31, 2006
|
|||||
ASSETS
|
|||||||
Cash
and cash equivalents
|
$
|
5,791,569
|
$
|
14,835,500
|
|||
Investments
at fair value, cost of $41,810,442
|
|||||||
and
$38,413,046 at September 30, 2007 and
|
|||||||
December
31, 2006, respectively
|
39,548,567
|
43,642,143
|
|||||
Due
from broker
|
644,091
|
—
|
|||||
Interest
and dividends receivable
|
88,197
|
146,146
|
|||||
Prepaid
and other assets
|
66,998
|
25,766
|
|||||
$
|
46,139,422
|
$
|
58,649,555
|
||||
LIABILITIES
AND NET ASSETS
|
|||||||
Liabilities:
|
|||||||
Accounts
payable
|
69,423
|
168,845
|
|||||
Due
to broker
|
664,117
|
—
|
|||||
Accounts
payable - affiliate
|
708,443
|
3,810,462
|
|||||
Taxes
payable on behalf of stockholders
|
—
|
6,302,806
|
|||||
1,441,983
|
10,282,113
|
||||||
Commitments
and contingencies
|
|||||||
Net
assets:
|
|||||||
Common
stock, $1 par value; authorized
|
|||||||
20,000,000
shares; 4,673,867 issued;
|
|||||||
4,463,967
shares outstanding
|
4,673,867
|
4,673,867
|
|||||
Additional
paid-in-capital
|
27,894,993
|
28,494,233
|
|||||
Treasury
stock at cost, 209,900 shares
|
(1,734,967
|
)
|
(1,734,967
|
)
|
|||
Distributable
earnings
|
4,420,209
|
—
|
|||||
Net
realized gain on investments retained
|
11,705,212
|
11,705,212
|
|||||
Net
unrealized appreciation (depreciation) of investments
|
(2,261,875
|
)
|
5,229,097
|
||||
Net
assets, equivalent to $10.01 and $10.84
|
|||||||
per
share at September 30,2007 and
|
|||||||
December
31, 2006, respectively
|
44,697,439
|
48,367,442
|
|||||
$
|
46,139,422
|
$
|
58,649,555
|
See
accompanying notes
3
Renaissance
Capital Growth & Income Fund III, Inc.
Schedules
of Investments
(unaudited)
September
30, 2007
|
||||||||||||||||
|
|
Interest
Rate
|
|
Due
Date
|
|
Cost
|
|
Fair
(1)
Value
|
|
%
of Net
Investments
|
||||||
Eligible
Portfolio Investments -
|
||||||||||||||||
Convertible
Debentures and
|
||||||||||||||||
Promissory
Notes
|
||||||||||||||||
CaminoSoft
Corp. -
|
||||||||||||||||
Promissory
note (3)
|
7.00
|
%
|
01/19/08
|
$
|
250,000
|
$
|
250,000
|
0.63
|
%
|
|||||||
iLinc
Communications, Inc. -
|
||||||||||||||||
Convertible
debenture (2)
|
12.00
|
03/29/12
|
500,000
|
500,000
|
1.26
|
|||||||||||
Integrated
Security Systems, Inc. -
|
||||||||||||||||
Convertible
promissory note (3)
|
6.00
|
09/30/07
|
400,000
|
400,000
|
1.02
|
|||||||||||
Promissory
note (3)
|
7.00
|
09/30/07
|
200,000
|
200,000
|
0.51
|
|||||||||||
Promissory
note (3)
|
8.00
|
09/30/07
|
525,000
|
525,000
|
1.33
|
|||||||||||
Promissory
note (3)
|
8.00
|
09/30/07
|
450,000
|
450,000
|
1.14
|
|||||||||||
Promissory
note (3)
|
8.00
|
11/06/07
|
175,000
|
175,000
|
0.44
|
|||||||||||
Promissory
note (3)
|
8.00
|
12/14/08
|
500,000
|
500,000
|
1.26
|
|||||||||||
Pipeline
Data
|
||||||||||||||||
Convertible
debenture
|
8.00
|
06/29/10
|
500,000
|
500,000
|
1.26
|
|||||||||||
Simtek
Corporation -
|
||||||||||||||||
Convertible
debenture (3)
|
7.50
|
06/28/09
|
700,000
|
1,288,637
|
3.26
|
|||||||||||
$
|
4,200,000
|
$
|
4,788,637
|
12.11
|
%
|
See
accompanying notes
4
Renaissance
Capital Growth & Income Fund III, Inc.
Schedules
of Investments (continued)
(unaudited)
September
30, 2007
|
|||||||||||||
Shares
|
Cost
|
Fair
(1)
Value
|
%
of Net
Investments
|
||||||||||
Eligible
Portfolio Investments -
|
|||||||||||||
Common
Stock, Preferred Stock,
|
|||||||||||||
and
Miscellaneous Securities
|
|||||||||||||
Advance
Nanotech
|
|||||||||||||
Common
stock
|
5,796
|
$
|
11,199
|
$
|
1,565
|
0.01
|
|||||||
AuraSound,
Inc.
|
|||||||||||||
Common
stock
|
1,000,000
|
1,000,000
|
1,100,000
|
2.78
|
|||||||||
BPO
Management Services, Inc.
|
|||||||||||||
Series
D Preferred (3)
|
104,167
|
1,000,000
|
1,250,000
|
3.16
|
|||||||||
CaminoSoft
Corp. -
|
|||||||||||||
Common
stock (3)
|
5,275,000
|
5,275,000
|
460,124
|
1.16
|
|||||||||
Digital
Learning Institute, Inc. -
|
|||||||||||||
Common
stock (2)
|
166,666
|
12,500
|
16,000
|
0.04
|
|||||||||
eOriginal,
Inc. -
|
|||||||||||||
Series
A, preferred stock (3)
|
10,680
|
4,692,207
|
332,575
|
0.84
|
|||||||||
Series
B, preferred stock (3)
|
25,646
|
620,329
|
798,616
|
2.02
|
|||||||||
Series
C, preferred stock (3)
|
51,249
|
1,059,734
|
1,595,894
|
4.04
|
|||||||||
Series
D, preferred stock (3)
|
16,057
|
500,000
|
500,015
|
1.26
|
|||||||||
|
|||||||||||||
Gaming
& Entertainment Group -
|
|||||||||||||
Common
stock (2)
|
612,500
|
550,625
|
18,375
|
0.05
|
|||||||||
Gasco
Energy, Inc. -
|
|||||||||||||
Common
stock
|
1,541,666
|
1,250,000
|
2,867,499
|
7.25
|
|||||||||
Global
Axcess Corporation -
|
|||||||||||||
Common
stock (2)
|
953,333
|
1,261,667
|
286,000
|
0.72
|
|||||||||
Hemobiotech,
Inc. -
|
|||||||||||||
Common
stock (2)
|
1,200,000
|
1,284,117
|
1,980,000
|
5.02
|
|||||||||
I2
Telecom -
|
|||||||||||||
Common
stock
|
4,165,316
|
711,200
|
583,144
|
1.47
|
|||||||||
Integrated
Security Systems, Inc. -
|
|||||||||||||
Common
stock (3)
|
32,774,091
|
6,048,292
|
2,294,186
|
5.80
|
|||||||||
Series
D convertible preferred stock (3)
|
187,500
|
150,000
|
13,125
|
0.03
|
See
accompanying notes
5
Renaissance
Capital Growth & Income Fund III, Inc.
Schedules
of Investments (continued)
(unaudited)
September
30, 2007
|
|||||||||||||
|
|
|
Fair
(1)
|
|
%
of Net
|
|
|||||||
|
|
Shares
|
|
Cost
|
|
Value
|
|
Investments
|
|||||
Eligible
Portfolio Investments -
|
|||||||||||||
Common
Stock, Preferred Stock,
|
|||||||||||||
and
Miscellaneous Securities, continued
|
|||||||||||||
Murdoch
Security & Investigations, Inc.-
|
|||||||||||||
Common
stock (2)
|
1,000,000
|
500,000
|
500,000
|
1.26
|
|||||||||
Narrowstep,
Inc. -
|
|||||||||||||
Common
stock (2)
|
4,000,000
|
1,000,000
|
2,160,000
|
5.46
|
|||||||||
Shea
Development Corp. -
|
|||||||||||||
Common
stock (3)
|
1,838,396
|
1,093,332
|
919,198
|
2.32
|
|||||||||
Simtek
Corp. -
|
|||||||||||||
Common
stock (3)
|
731,672
|
1,999,294
|
2,963,272
|
7.49
|
|||||||||
Symbollon
Pharmaceuticals, Inc. -
|
|||||||||||||
Common
stock (2)
|
607,143
|
500,000
|
540,357
|
1.37
|
|||||||||
Miscellaneous
Eligible Securities (4)
|
-
|
311,951
|
0.79
|
||||||||||
$
|
30,519,496
|
$
|
21,491,896
|
54.34
|
%
|
See
accompanying notes
6
Renaissance
Capital Growth & Income Fund III, Inc.
Schedules
of Investments (continued)
(unaudited)
September
30, 2007
|
|||||||||||||
|
|
|
|
Fair
(1)
|
|
%
of Net
|
|
||||||
|
|
Shares
|
|
Cost
|
|
Value
|
|
Investments
|
|||||
Other
Portfolio Investments -
|
|||||||||||||
Common
Stock, Preferred Stock,
|
|||||||||||||
and
Miscellaneous Securities
|
|||||||||||||
Access
Plans (Precis) -
|
|||||||||||||
Common
stock (3)
|
890,500
|
$ |
2,139,777
|
$
|
1,317,940
|
3.33
|
%
|
||||||
AdStar,
Inc. -
|
|||||||||||||
Common
stock
|
269,231
|
350,000
|
188,462
|
0.48
|
|||||||||
Asian
Financial, Inc. -
|
|||||||||||||
Common
stock (2)
|
130,209
|
500,000
|
500,000
|
1.26
|
|||||||||
Bovie
Medical Corporation -
|
|||||||||||||
Common
stock (2)
|
500,000
|
907,845
|
3,498,500
|
8.85
|
|||||||||
Comtech
Group, Inc. -
|
|||||||||||||
Common
stock
|
200,000
|
836,019
|
3,642,000
|
9.21
|
|||||||||
Chardan
South China Acquisition Corp. -
|
|||||||||||||
Common
stock
|
48,000
|
409,256
|
430,080
|
1.09
|
|||||||||
HLS
Systems International, Ltd.-
|
|||||||||||||
Common
stock
|
58,500
|
498,557
|
483,795
|
1.22
|
|||||||||
iLinc
Communications, Inc. -
|
|||||||||||||
Common
stock
|
23,266
|
13,908
|
14,658
|
0.04
|
|||||||||
Medical
Action Industries, Inc. -
|
|||||||||||||
Common
stock
|
30,150
|
237,209
|
713,349
|
1.80
|
|||||||||
Points
International, Ltd. -
|
|||||||||||||
Common
stock
|
900,000
|
492,000
|
1,557,000
|
3.94
|
See
accompanying notes
7
Renaissance
Capital Growth & Income Fund III, Inc.
Schedules
of Investments (continued)
(unaudited)
September
30, 2007
|
|||||||||||||
Fair
(1)
|
|
%
of Net
|
|||||||||||
Shares
|
|
Cost
|
|
Value
|
|
Investments
|
|||||||
Other
Portfolio Investments -
|
|||||||||||||
Common
Stock, Preferred Stock,
|
|||||||||||||
and
Miscellaneous Securities, continued
|
|||||||||||||
Silverleaf
Resorts, Inc. -
|
|||||||||||||
Common
stock
|
100,000
|
430,000
|
529,000
|
1.34
|
|||||||||
US
Home Systems, Inc. -
|
|||||||||||||
Common
stock
|
55,000
|
276,375
|
393,250
|
0.99
|
|||||||||
Miscellaneous
Other Securities (4)
|
-
|
-
|
0.00
|
||||||||||
7,090,946
|
13,268,034
|
33.55
|
%
|
||||||||||
$
|
41,810,442
|
$
|
39,548,567
|
100.00
|
%
|
||||||||
Allocation
of Investments -
|
|||||||||||||
Restricted
Shares, Unrestricted Shares,
|
|||||||||||||
and
Other Securities
|
|||||||||||||
Restricted
Securities (2)(3)
|
$
|
34,794,719
|
$
|
26,232,814
|
66.33
|
%
|
|||||||
Unrestricted
Securities
|
$
|
7,015,723
|
$
|
13,003,802
|
32.88
|
%
|
|||||||
Other
Securities (4)
|
$
|
0
|
$
|
311,951
|
0.79
|
%
|
(1) Valued
at
fair value as determined by the Investment Adviser (Note 6).
(2) Restricted
securities from a non-public company, or not fully registered, or held less
than
two years.
(3) Restricted
securities due to having a director on issuer’s board.
(4) Includes
Miscellaneous Securities, such as warrants and options.
See
accompanying notes
8
Renaissance
Capital Growth & Income Fund III, Inc.
Schedules
of Investments
(unaudited)
December
31, 2006
|
||||||||||||||||
Interest
|
|
Due
|
|
|
|
Fair(1)
|
|
%
of Net
|
|
|||||||
|
|
Rate
|
|
Date
|
|
Cost
|
|
Value
|
|
Investments
|
||||||
Eligible
Portfolio Investments -
|
||||||||||||||||
Convertible
Debentures and
|
||||||||||||||||
Promissory
Notes
|
||||||||||||||||
CaminoSoft
Corp. -
|
||||||||||||||||
Promissory
note (4)
|
7.00
|
%
|
01/19/08
|
$
|
250,000
|
$
|
250,000
|
0.57
|
%
|
|||||||
iLinc
Communications, Inc. -
|
||||||||||||||||
Convertible
promissory note
|
12.00
|
03/29/12
|
500,000
|
500,000
|
1.15
|
|||||||||||
Integrated
Security Systems, Inc. -
|
||||||||||||||||
Promissory
note (4)
|
8.00
|
09/30/07
|
525,000
|
525,000
|
1.20
|
|||||||||||
Promissory
note (4)
|
7.00
|
09/30/07
|
200,000
|
200,000
|
0.46
|
|||||||||||
Promissory
note (4)
|
8.00
|
09/30/07
|
175,000
|
175,000
|
0.40
|
|||||||||||
Convertible
promissory note (2)
|
8.00
|
12/14/08
|
500,000
|
500,000
|
1.15
|
|||||||||||
Convertible
debenture (4)
|
6.00
|
06/16/09
|
400,000
|
400,000
|
0.91
|
|||||||||||
Pipeline
Data, Inc. -
|
||||||||||||||||
Convertible
debenture (2)
|
8.00
|
06/29/10
|
500,000
|
500,000
|
1.15
|
|||||||||||
Simtek
Corporation -
|
||||||||||||||||
Convertible
debenture
|
7.50
|
06/28/09
|
900,000
|
1,902,273
|
4.36
|
|||||||||||
$
|
3,950,000
|
$
|
4,952,273
|
11.35
|
%
|
See
accompanying notes
9
Renaissance
Capital Growth & Income Fund III, Inc.
Schedules
of Investments
(unaudited)
December
31, 2006
|
|||||||||||||
Fair
(1)
|
|
%
of Net
|
|||||||||||
Shares
|
|
Cost
|
|
Value
|
|
Investments
|
|||||||
Eligible
Portfolio Investments -
|
|||||||||||||
Common
Stock, Preferred Stock,
|
|||||||||||||
and
Miscellaneous Securities
|
|||||||||||||
Advance
Nanotech, Inc. -
|
|||||||||||||
Common
stock (2)
|
170,796
|
$
|
330,000
|
$
|
121,265
|
0.28
|
%
|
||||||
CaminoSoft
Corp. -
|
|||||||||||||
Common
stock
|
3,539,414
|
5,275,000
|
1,592,736
|
3.65
|
|||||||||
Digital
Learning Management Corporation -
|
|||||||||||||
Common
stock (2)
|
166,666
|
12,500
|
13,333
|
0.03
|
|||||||||
eOriginal,
Inc. -
|
|||||||||||||
Series
A, preferred stock (1)(3)
|
10,680
|
4,692,207
|
332,575
|
0.76
|
|||||||||
Series
B, preferred stock (1)(3)
|
25,646
|
620,329
|
798,616
|
1.83
|
|||||||||
Series
C, preferred stock (1)(3)
|
51,249
|
1,059,734
|
1,595,894
|
3.66
|
|||||||||
Series
D, preferred stock (1)(3)
|
16,057
|
500,000
|
500,015
|
1.15
|
|||||||||
Gaming
& Entertainment Group, Inc. -
|
|||||||||||||
Common
stock
|
500,000
|
500,000
|
12,500
|
0.03
|
|||||||||
Common
stock (2)
|
112,500
|
50,625
|
2,813
|
0.01
|
|||||||||
Gasco
Energy, Inc. -
|
|||||||||||||
Common
stock
|
1,541,666
|
1,250,000
|
3,777,082
|
8.65
|
|||||||||
Global
Axcess Corporation -
|
|||||||||||||
Common
stock
|
953,333
|
1,261,667
|
352,733
|
0.81
|
|||||||||
Hemobiotech,
Inc. -
|
|||||||||||||
Common
stock
|
1,137,405
|
1,143,882
|
2,331,680
|
5.34
|
|||||||||
i2
Telecom -
|
|||||||||||||
Convertible
Preferred (2)
|
625
|
618,750
|
85,938
|
0.20
|
|||||||||
Common
stock (2)
|
237,510
|
36,200
|
26,126
|
0.06
|
|||||||||
Information
Intellect -
|
|||||||||||||
Common
stock (1)(3)
|
666,666
|
999,999
|
999,999
|
2.29
|
See
accompanying notes
10
Renaissance
Capital Growth & Income Fund III, Inc.
Schedules
of Investments (continued)
(unaudited)
December
31, 2006
|
|||||||||||||
Fair
(1)
|
|
%
of Net
|
|||||||||||
Shares
|
|
Cost
|
|
Value
|
|
Investments
|
|||||||
Eligible
Portfolio Investments -
|
|||||||||||||
Common
Stock, Preferred Stock,
|
|||||||||||||
and
Miscellaneous Securities, continued
|
|||||||||||||
Integrated
Security Systems, Inc. -
|
|||||||||||||
Common
stock
|
27,074,179
|
5,568,054
|
3,790,385
|
8.70
|
|||||||||
Common
stock (2)
|
4,264,854
|
356,225
|
597,080
|
1.36
|
|||||||||
Series
D, preferred stock (2)
|
187,500
|
150,000
|
26,250
|
0.06
|
|||||||||
Inyx,
Inc. -
|
|||||||||||||
Common
stock
|
300,000
|
300,000
|
699,000
|
1.60
|
|||||||||
PracticeXpert,
Inc. -
|
|||||||||||||
Common
stock
|
4,166,667
|
500,000
|
12,500
|
0.03
|
|||||||||
Simtek
Corp. -
|
|||||||||||||
Common
stock
|
639,603
|
1,795,000
|
2,974,153
|
6.81
|
|||||||||
Common
stock (2)
|
1,160
|
4,294
|
5,392
|
0.01
|
|||||||||
Symbollon
Pharmaceuticals, Inc. -
|
|||||||||||||
Common
stock (2)
|
250,000
|
250,000
|
225,000
|
0.51
|
|||||||||
Miscellaneous
Securities
|
-
|
407,822
|
0.93
|
||||||||||
$
|
27,274,466
|
$
|
21,280,887
|
48.76
|
%
|
See
accompanying notes
11
Renaissance
Capital Growth & Income Fund III, Inc.
Schedules
of Investments (continued)
(unaudited)
December
31, 2006
|
|
||||||||||||
|
|
|
|
|
|
Fair
(1)
|
|
%
of Net
|
|
||||
|
|
Shares
|
|
Cost
|
|
Value
|
|
Investments
|
|||||
Other
Portfolio Investments -
|
|||||||||||||
Common
Stock, Preferred Stock,
|
|||||||||||||
and
Miscellaneous Securities
|
|||||||||||||
AdStar,
Inc. -
|
|||||||||||||
Common
stock
|
269,231
|
$
|
350,000
|
$
|
619,231
|
1.42
|
%
|
||||||
Asian
Financial, Inc. -
|
|||||||||||||
Common
stock (1)(3)
|
130,208
|
500,000
|
500,000
|
1.15
|
|||||||||
Bovie
Medical Corporation -
|
|||||||||||||
Common
stock
|
500,000
|
907,845
|
4,535,000
|
10.39
|
|||||||||
China
Security & Surveillance Technology, Inc. -
|
|||||||||||||
Common
stock (2)
|
142,857
|
500,000
|
1,728,570
|
3.96
|
|||||||||
Comtech
Group, Inc. -
|
|||||||||||||
Common
stock
|
300,000
|
1,186,019
|
5,457,000
|
12.51
|
|||||||||
Hemobiotech,
Inc. -
|
|||||||||||||
Common
stock
|
62,595
|
140,235
|
128,320
|
0.29
|
|||||||||
iLinc
Communications, Inc. -
|
|||||||||||||
Common
stock
|
23,266
|
13,908
|
13,727
|
0.03
|
|||||||||
Medical
Action Industries, Inc. -
|
|||||||||||||
Common
stock
|
20,100
|
237,209
|
648,024
|
1.49
|
See
accompanying notes
12
Renaissance
Capital Growth & Income Fund III, Inc.
Schedules
of Investments (continued)
(unaudited)
December
31, 2006
|
|||||||||||||
Fair
(1)
|
|
%
of Net
|
|||||||||||
Shares
|
|
Cost
|
|
Value
|
|
Investments
|
|||||||
Other
Portfolio Investments -
|
|||||||||||||
Common
Stock, Preferred Stock,
|
|||||||||||||
and
Miscellaneous Securities, continued
|
|||||||||||||
Points
International, Ltd. -
|
|||||||||||||
Common
stock
|
800,000
|
428,000
|
512,000
|
1.17
|
|||||||||
Precis,
Inc. -
|
|||||||||||||
Common
stock
|
890,500
|
2,139,777
|
1,786,343
|
4.09
|
|||||||||
US
Home Systems, Inc. -
|
|||||||||||||
Common
stock
|
110,000
|
535,587
|
1,245,200
|
2.85
|
|||||||||
Vaso
Active Pharmaceuticals, Inc. -
|
|||||||||||||
Common
stock
|
150,000
|
250,000
|
27,000
|
0.06
|
|||||||||
Miscellaneous
Securities
|
-
|
208,568
|
0.48
|
||||||||||
7,188,580
|
17,408,983
|
39.89
|
%
|
||||||||||
$
|
38,413,046
|
$
|
43,642,143
|
100.00
|
%
|
Allocation
of Investments -
|
||||||||||
Restricted
Shares, Unrestricted Shares,
|
||||||||||
and
Other Securities
|
||||||||||
Restricted
Securities (2)
|
$
|
3,308,594
|
$
|
3,831,767
|
8.78
|
%
|
||||
Unrestricted
Securities
|
$
|
25,182,183
|
$ | 32,916,887 |
75.42
|
%
|
||||
Other
Securities (5)
|
$
|
9,922,269
|
$
|
6,893,489
|
15.80
|
%
|
(1) |
Valued
at fair value as determined by the Investment Adviser (Note
6).
|
(2)
|
Restricted
securities - securities that are not freely tradable (there is not
a valid
registration statement on file or an available exemption from
registration.)
|
(3) |
Securities
in a privately held company, which by nature are restricted securities
(not freely tradable).
|
(4) |
Securities
that have no provision allowing conversion into a security for which
there
is a public market.
|
(5)
|
Miscellaneous
securities, securities of privately held companies and securities
with no
conversion feature.
|
See
accompanying notes
13
Renaissance
Capital Growth & Income Fund III, Inc.
Statements
of Operations
(Unaudited)
Three
Months Ended
September
30,
|
|
||||||
|
|
2007
|
|
2006
|
|||
Income:
|
|||||||
Interest
income
|
$
|
85,979
|
$
|
125,296
|
|||
Dividend
income
|
106,209
|
232,992
|
|||||
192,188
|
358,288
|
||||||
Expenses:
|
|||||||
General
and administrative
|
91,082
|
63,538
|
|||||
Legal
and professional fees
|
66,348
|
140,140
|
|||||
Management
fee to affiliate
|
196,411
|
237,776
|
|||||
353,841
|
441,454
|
||||||
Net
investment loss
|
(161,653
|
)
|
(83,166
|
)
|
|||
Realized
and unrealized gain (loss)
|
|||||||
on
investments:
|
|||||||
Net
change in unrealized appreciation (depreciation)
|
|||||||
of
investments
|
(6,259,982
|
)
|
(2,379,862
|
)
|
|||
Net
realized gain on investments
|
2,386,440
|
874,823
|
|||||
Net
loss on investments
|
(3,873,542
|
)
|
(1,505,039
|
)
|
|||
Net
loss
|
$
|
(4,035,195
|
)
|
$
|
(1,588,205
|
)
|
|
Net
loss per share
|
$
|
(0.90
|
)
|
$
|
(0.36
|
)
|
|
Weighted
average shares outstanding
|
4,463,967
|
4,463,967
|
See
accompanying notes
14
Renaissance
Capital Growth & Income Fund III, Inc.
Statements
of Operations
(Unaudited)
Nine
Months Ended
September
30,
|
|
||||||
|
|
2007
|
|
2006
|
|||
Income:
|
|||||||
Interest
income
|
$
|
244,616
|
$
|
244,630
|
|||
Dividend
income
|
386,696
|
347,037
|
|||||
Other
income
|
14,587
|
19,954
|
|||||
645,899
|
611,621
|
||||||
Expenses:
|
|||||||
General
and administrative
|
345,792
|
235,777
|
|||||
Interest
expense
|
—
|
60,188
|
|||||
Legal
and professional fees
|
274,685
|
483,288
|
|||||
Management
fee to affiliate
|
624,662
|
723,239
|
|||||
1,245,139
|
1,502,492
|
||||||
Net
investment loss
|
(599,240
|
)
|
(890,871
|
)
|
|||
Realized
and unrealized gain (loss)
|
|||||||
on
investments:
|
|||||||
Net
change in unrealized appreciation (depreciation)
|
|||||||
of
investments
|
(7,490,972
|
)
|
(17,533,952
|
)
|
|||
Net
realized gain on investments
|
4,420,209
|
19,686,060
|
|||||
Net
gain (loss) on investments
|
(3,070,763
|
)
|
2,152,108
|
||||
Net
income (loss)
|
$
|
(3,670,003
|
)
|
$
|
1,261,237
|
||
Net
income (loss) per share
|
$
|
(0.82
|
)
|
$
|
0.28
|
||
Weighted
average shares outstanding
|
4,463,967
|
4,463,967
|
See
accompanying notes
15
Renaissance
Capital Growth & Income Fund III, Inc.
Statements
of Changes in Net Assets
(Unaudited)
Nine
Months Ended
September
30,
|
|
||||||
|
|
2007
|
|
2006
|
|||
From
operations:
|
|||||||
Net
investment loss
|
$
|
(599,240
|
)
|
$
|
(890,871
|
)
|
|
Net
realized gain on investments
|
4,420,209
|
19,686,060
|
|||||
Net
decrease in unrealized appreciation on investments
|
(7,490,972
|
)
|
(17,533,952
|
)
|
|||
Net
income (loss)
|
(3,670,003
|
)
|
1,261,237
|
||||
From
distributions to stockholders:
|
|||||||
Common
stock dividends from realized
|
|||||||
capital
gains
|
—
|
(1,339,190
|
)
|
||||
Total
decrease in net assets
|
(3,670,003
|
)
|
(77,953
|
)
|
|||
Net
assets:
|
|||||||
Beginning
of period
|
48,367,442
|
54,188,943
|
|||||
End
of period
|
$
|
44,697,439
|
$
|
54,110,990
|
See
accompanying notes
16
Renaissance
Capital Growth & Income Fund III, Inc.
Statements
of Cash Flows
(Unaudited)
Nine
Months Ended September 30,
|
|||||||
2007
|
|
2006
|
|||||
Cash
flows from operating activities:
|
|||||||
Net
income (loss)
|
$
|
(3,670,003
|
)
|
$
|
1,261,237
|
||
Adjustments
to reconcile net income (loss) to net cash
|
|||||||
provided
by (used in) operation activities:
|
|||||||
Net
decrease in unrealized depreciation on investments
|
7,490,972
|
17,533,952
|
|||||
Net
realized gain on investments
|
(4,420,209
|
)
|
(19,686,060
|
)
|
|||
Increase
in due from broker
|
(644,091
|
)
|
—
|
||||
(Increase)
decrease in interest and dividends receivable
|
57,949
|
(88,197
|
)
|
||||
(Increase)
decrease in prepaid and other assets
|
(41,232
|
)
|
90,677
|
||||
Increase
(decrease) in due from broker
|
664,117
|
(2,075,975
|
)
|
||||
Increase
(decrease) in accounts payable
|
(99,422
|
)
|
32,531
|
||||
Decrease
in accounts payable-affiliate
|
(3,102,019
|
)
|
(1,377,226
|
)
|
|||
Decrease
in taxes payable on behalf of stockholders
|
(6,302,806
|
)
|
—
|
||||
Purchase
of investments
|
(6,012,549
|
)
|
(2,984,342
|
)
|
|||
Proceeds
from sale of investments
|
7,035,362
|
20,823,298
|
|||||
Net
cash provided by (used in) operating activities
|
(9,043,931 |
)
|
13,529,895
|
||||
Cash
flows from financing activities:
|
|||||||
Cash
dividends
|
—
|
(5,484,876
|
)
|
||||
Net
increase (decrease) in cash
|
|||||||
and
cash equivalents
|
(9,043,931
|
)
|
8,045,019
|
||||
Cash
and cash equivalents at beginning
|
|||||||
of
the period
|
14,835,500
|
8,396,052
|
|||||
Cash
and cash equivalents at end of period
|
$
|
5,791,569
|
$
|
16,441,071
|
|||
Cash
paid during the period
|
|||||||
Interest
|
$
|
—
|
$
|
60,188
|
See
accompanying notes
17
Renaissance
Capital Growth & Income Fund III, Inc.
Notes
to
Unaudited Financial Statements
September
30, 2007
Note 1 - |
Organization
and Business Purpose
|
Renaissance
Capital Growth & Income Fund III, Inc. (the “Fund”), a Texas corporation,
was formed on January 20, 1994. The Fund seeks to achieve current income and
capital appreciation potential by investing primarily in unregistered equity
investments and convertible issues of small and medium size companies which
are
in need of capital and which RENN Capital Group, Inc. (the “Investment Advisor”)
believes offer the opportunity for growth. The Fund is a non-diversified
closed-end fund and has elected to be treated as a business development company
under the Investment Company Act of 1940, as amended (“1940 Act”).
Note 2 - |
Summary
of Significant Accounting
Policies
|
Basis
of Presentation
We
have
prepared the accompanying unaudited interim financial statements pursuant
to the
rules and regulations of the Securities and Exchange Commission, which
reflect
all adjustments which, in the opinion of management, are necessary to present
fairly the results for the interim periods. We have omitted certain information
and disclosures normally included in annual financial statements prepared
in
accordance with accounting principles generally accepted in the United
States
pursuant to those rules and regulations, although we believe that the
disclosures we have made are adequate to make the information presented
not
misleading. You should read these unaudited interim financial statements
in
conjunction with our audited financial statements and notes included in
our
Annual Report on Form 10-K for the year ended December 31,
2006.
The
results of operations for the interim periods are not necessarily indicative
of
the results we expect for the full year.
Valuation
of Investments
Portfolio
investments are stated at quoted market or fair value as determined by the
Investment Adviser (Note 6). The securities held by the Fund are primarily
unregistered and their value does not necessarily represent the amounts that
may
be realized from their immediate sale or disposition.
Other
The
Fund
follows industry practice and records security transactions on the trade date.
Dividend income is recorded on the record date. Interest income is recorded
as
earned on the accrual basis.
Cash
and Cash Equivalents
The
Fund
considers all highly liquid debt instruments with original maturities of three
months or less to be cash equivalents.
Income
Taxes
The
Fund
has elected the special income tax treatment available to “regulated investment
companies” (“RIC”) under Subchapter M of the Internal Revenue Code (“IRC”) which
allows the Fund to be relieved of federal income tax on that part of its net
investment income and realized capital gains that it pays out to its
shareholders. The Fund’s policy is to comply with the requirements of the IRC
that are applicable to regulated investment companies. Such requirements
include, but are not limited to certain qualifying income tests, asset
diversification tests and distribution of substantially all of the Fund’s
taxable investment income to its shareholders. It is the intent of management
to
comply with all IRC requirements
as they pertain to a RIC and to distribute all of the Fund’s taxable investment
income and long-term capital gains within the defined period under the IRC
to
qualify as a RIC. Failure to qualify as a RIC would subject the Fund to federal
income tax as if the Fund were an ordinary corporation, which could result
in a
substantial reduction in the Fund’s net assets as well as the amount of cash
available for distribution to shareholders.
18
Renaissance
Capital Growth & Income Fund III, Inc.
Notes
to
Unaudited Financial Statements (continued)
September
30, 2007
Federal
income taxes payable on behalf of stockholders on realized gains that the Fund
elects to retain are accrued and reflected as a tax expense paid on behalf
of
stockholders on the last day of the tax year in which such gains are
realized.
In
January 2007 the Fund adopted the Financial Accounting Standards Board
Interpretation No. 48, “Accounting for Uncertainty in Income Taxes - An
Interpretation of FASB Statement No. 109” (“FIN 48”). This Interpretation
clarifies the accounting for uncertainty in income taxes recognized in a
company’s financial statements. FIN 48 requires companies to determine whether
it is “more likely than not” that a tax position will be sustained upon
examination by the appropriate taxing authorities before any part of the benefit
can be recorded in the financial statements. It also provides guidance on the
recognition, measurement and classification of income tax uncertainties, along
with any related interest and penalties. The Fund did not recognize any
adjustments to the Fund’s financial statements as a result of the implementation
of FIN 48.
The
Texas
franchise tax laws were changed in 2006, and the Fund became subject to the
Texas Margin Tax, effective January 1, 2007.
Net
Income (Loss) Per Share
Net
income (loss) per share is based on the weighted average number of shares
outstanding of 4,463,967 during the three and nine months ended September
30, 2007
and
2006.
Use
of Estimates
The
preparation of financial statements in conformity with accounting principles
generally accepted in the United States of America requires management to make
estimates and assumptions that affect the amounts and disclosures in the
financial statements. Actual results could differ from these
estimates.
Note 3 - |
Due
to/from Broker
|
The
Fund
conducts business with various brokers for its investment activities. The
clearing and depository operations for the investment activities are performed
pursuant to agreements with these brokers. “Due to broker” represents unsettled
purchase transactions and “due from broker” represents unsettled sales
transactions. The Fund is subject to credit risk to the extent the brokers
are
unable to deliver cash balances or securities, or clear security transactions
on
the Fund’s behalf. The Investment Adviser actively monitors the Fund’s exposure
to these brokers and believes the likelihood of loss under those circumstances
is remote.
Note 4 - |
Management
and Incentive Fees
|
The
Investment Adviser for the Fund is registered as an investment adviser under
the
Investment Advisers Act of 1940. Pursuant to an Investment Advisory Agreement
(the “Agreement”), the Investment Adviser performs certain services, including
certain management, investment advisory and administrative
services necessary for the operation of the Fund. In addition, under the
Agreement, the Investment
19
Renaissance
Capital Growth & Income Fund III, Inc.
Notes
to
Unaudited Financial Statements (continued)
September
30, 2007
Adviser
is reimbursed by the Fund for certain directly allocable administrative
expenses. A summary of fees and reimbursements paid by the Fund under the
Agreement is as follows:
The
Investment Adviser receives a management fee equal to a quarterly rate of
0.4375% of the Fund’s net assets, as determined at the end of such quarter, each
payment to be due as of the last day of the calendar quarter. The Fund incurred
$624,662
and
$723,239 for management fees during the nine months ended September
30, 2007
and
2006, respectively.
The
Investment Adviser receives an incentive fee in an amount equal to 20% of the
Fund’s cumulative realized capital gains in excess of cumulative capital losses
of the Fund after allowance for any unrealized capital depreciation on the
portfolio investments of the Fund at the end of the period being calculated
less
cumulative incentive fees previously accrued. Unrealized capital depreciation
equals net unrealized capital losses on each class of security without netting
net unrealized capital gains on other classes of securities. The incentive
fee
is calculated, accrued, and paid on an annual basis as of year end. Because
the
incentive fee is calculated, accrued, and paid on an annual basis as of each
year end and no probability or estimate of the ultimate fee can be ascertained
(see note 9), no incentive fee was recorded during the nine months ended
September
30, 2007
and
2006. At December 31, 2006, the Fund had recorded an accounts payable of
$3,136,699 for the 2006 incentive fee.
The
Investment Adviser was reimbursed by the Fund for directly allocable
administrative expenses paid by the Investment Adviser on behalf of the Fund.
Such reimbursements were $144,122 and $49,977 during the nine months ended
September
30, 2007
and
2006,
respectively.
As
of
September
30, 2007
and
December
31, 2006,
the
Fund had an accounts payable of $708,443
and
$673,763, respectively, for the amount due for the fees and expense
reimbursements disclosed above.
Note 5 - |
Eligible
Portfolio Companies and
Investments
|
Eligible
Portfolio Companies
The
Fund
invests primarily in convertible securities and equity investments of companies
that qualify as Eligible Portfolio Companies as defined in Section 2(a)(46)
of
the 1940 Act or in securities that otherwise qualify for investment as permitted
in Section 55(a)(1) through (5) of the 1940 Act. Under the provisions of the
1940 Act at least 70% of the Fund’s total assets, as defined under Section 55 of
the 1940 Act, must be invested in Eligible Portfolio Companies, as defined
under
Section 2(a)(46) of the 1940 Act. In the event the Fund has less than 70% of
its
assets invested in Eligible Portfolio Investments, then the Fund will be
prohibited from making non-eligible investments until such time as the
percentage of eligible investments again exceeds the 70% threshold.
Investments
Investments
are carried in the statements of assets and liabilities at fair value, as
determined in good faith by the Investment Adviser, subject to the approval
of
the Fund’s Board of Directors. The convertible debt securities held by the Fund
generally have maturities between five and seven years and are convertible
(at
the discretion of the Fund) into the common stock of the issuer at a set
conversion price. The common stock underlying these securities is generally
unregistered and thinly to moderately traded, but is not otherwise restricted.
Generally, the Fund negotiates registration rights at the time of purchase
and
the portfolio companies are required to register the shares within a designated
period and the cost of registration is borne by the portfolio company. Interest
on the convertible securities is generally payable monthly. The convertible
debt
securities generally contain embedded call options giving the issuer the right
to call the underlying issue. In these instances, the Fund has the right of
redemption or conversion. The embedded call option will generally not vest
until
certain conditions are achieved by the issuer. Such conditions may require
that
minimum thresholds be met relating to underlying market prices, liquidity,
and
other factors.
20
Renaissance
Capital Growth & Income Fund III, Inc.
Notes
to
Unaudited Financial Statements (continued)
September
30, 2007
Note 6 - |
Valuation
of Investments
|
On
a
quarterly basis, the Investment Adviser prepares a valuation of the assets
of
the Fund,
subject
to the approval of the Board of Directors of the Fund. The valuation principles
are described below.
·
|
The
common stock of companies listed on an exchange, NASDAQ or in the
over-the-counter market is valued at the closing price on the date
of
valuation.
|
·
|
The
unlisted preferred stock of companies with common stock listed on
an
exchange, NASDAQ or in the over-the-counter market is valued at the
closing price of the common stock into which the preferred stock
is
convertible on the date of valuation. If the preferred stock is
redeemable, the preferred stock is valued at the greater of cost
or
market.
|
·
|
The
unlisted in-the-money options or warrants of companies with the underlying
common stock listed on an exchange, NASDAQ or in the over-the-counter
market are valued at the positive difference between the closing
price of
the underlying common stock and the strike price of the warrant or
option.
An out-of-the money warrant or option has no intrinsic value; thus,
we
assign no value to it.
|
·
|
Debt
securities are valued at the greater of (i) cost or (ii) the market
value
of the underlying common stock into which the debt instrument is
convertible. In cases where the debt instrument is in default or
the
company is in bankruptcy, the value will be (i) the value of the
underlying common stock, (ii) the value of the collateral, if secured,
or
(iii) zero, if the common stock has no value and there is no
collateral.
|
·
|
If
there is no independent and objective pricing authority (i.e. a public
market) for investments in privately held entities, the latest sale
of
equity securities to independent third parties by the entity governs
the
value of that enterprise. This valuation method causes the Fund’s initial
investment in the private entity to be valued at cost. Thereafter,
new
issuances or offers of equity or equity-linked securities by the
portfolio
company to new investors will be used to determine enterprise value
as
they will provide the most objective and independent basis for determining
the worth of the issuer. Where a private entity does not have an
independent value established over an extended period of time, then
the
Investment Adviser will determine fair value on the basis of appraisal
procedures established in good faith and approved by the Fund’s Board of
Directors.
|
As
of
September
30, 2007
and
December
31, 2006,
the net
unrealized appreciation (depreciation) associated with investments held by
the
Fund was $(2,261,875)
and
$5,229,097, respectively. As of September
30, 2007
and
December
31, 2006,
the
Fund had gross unrealized gains of $13,621,493 and $18,216,541, respectively,
and gross unrealized losses of $15,883,368 and $12,987,444,
respectively.
Note 7 - |
Restricted
Securities
|
As
indicated on the schedules of investments as of September
30, 2007
and
December
31, 2006,
the
Fund holds investments in shares of common stock, the sale of which is
restricted. These securities have been valued by the Investment Adviser (subject
to the approval of the Board of Directors of the Fund) after considering certain
pertinent factors relevant to the individual securities (See Note
6).
21
Renaissance
Capital Growth & Income Fund III, Inc.
Notes
to
Unaudited Financial Statements (continued)
September
30, 2007
Note 8 - |
Income
Taxes
|
Through
December 31, 2005, management followed a policy of distributing all of the
Fund’s taxable investment income and realized capital gains within the defined
period under the IRC to assure that any Federal income tax on such income,
if
any, is paid by the Fund’s stockholders. For this reason, no income tax was
reflected by the Fund through December 31, 2005.
During
December, 2006, the Board of Directors, in accordance with rules under
subchapter M of the IRC, declared a designated undistributed capital gain
dividend (“Deemed Distribution”) for 2006 on net taxable long-term capital gains
of $18,008,018. The Fund recorded a liability of $6,302,806 (which was paid
during the first quarter of 2007) on its statements of assets and liabilities
for taxes payable on behalf of its stockholders as of December 31, 2006. This
amount was also recorded as an income tax expense paid on behalf of stockholders
in the statements of operations for 2006.
Shareholders
of record at December 31, 2006, received a tax credit of $1.41 per share. The
balance of $11,705,212 was retained by the Fund.
Note 9 - |
Commitments
and Contingencies
|
As
disclosed in Note 4, the Fund is obligated to pay to the Investment Advisor
an
incentive fee equal to 20% of the Fund’s cumulative realized capital gains in
excess of cumulative capital losses of the Fund after allowance for any capital
depreciation on the portfolio investments of the Fund. As incentive fees on
capital gains are not due to the Investment Advisor until the capital gains
are
realized, any obligations for incentive fees based on unrealized capital gains
are not reflected in the accompanying financial statements as there is no
assurance that the unrealized gains as of the end of any period will ultimately
become realized. Had an incentive fee been accrued as a liability based on
all
unrealized capital gains, net assets of the Fund would have been reduced by
$3,029,156 and $3,643,308 as of September
30, 2007
and
December
31, 2006,
respectively.
22
Renaissance
Capital Growth & Income Fund III, Inc.
Notes
to
Unaudited Financial Statements (continued)
September
30, 2007
Note 10 - |
Financial
Highlights - unaudited
|
Selected
per share data and ratios for each share of common stock outstanding throughout
the nine months ended September
30, 2007
and
2006
are as
follows:
2007
|
2006
|
||||||
Net
asset value, beginning of period
|
$
|
10.84
|
$
|
12.14
|
|||
Net
investment loss
|
(0.14
|
)
|
(0.20
|
)
|
|||
Net
realized and unrealized gain (loss) on investments
|
(0.69
|
)
|
0.48
|
||||
Total
return from investment operations
|
(0.83
|
)
|
0.28
|
||||
Capital
share transactions
|
|||||||
Distribution:
|
—
|
(0.30
|
)
|
||||
Net
asset value, end of period
|
$
|
10.01
|
$
|
12.12
|
|||
Per
share market value, end of period
|
$
|
7.95
|
$
|
11.61
|
|||
Portfolio
turnover rate
|
10.80
|
%
|
6.40
|
%
|
|||
Nine
month return (a)
|
(24.26
|
)%
|
5.55
|
%
|
|||
Ratio
to average net assets: (b)
|
|||||||
Net
investment loss
|
(1.26
|
)%
|
(1.63
|
)%
|
|||
Expenses
|
2.61
|
%
|
2.75
|
%
|
(a)
|
Nine
month return (not annualized) was calculated by comparing the common
stock
price on the first day of the period to the common stock price on
the last
day of the period, in accordance with American Institute of Certified
Public Account guidelines.
|
(b) |
Average
net assets have been computed based on quarterly
valuations
|
23
Item
2. Management’s Discussion and Analysis of Financial Condition and Results of
Operations.
Material
Changes in Portfolio Investments [KM2]
The
following material portfolio transactions occurred during the quarter ended
September 30, 2007:
Chardan
South China Acquisition Corporation
(OTCBB:CSCA): During the third quarter of 2007, the Fund bought 48,000 shares
of
common stock for $409,256.
China
Security & Surveillance Technology, Inc. (OTCBB:CSCT):
In the quarter ended September 30, 2007, the Fund sold 157,828 shares of common
stock for $3,471,621, realizing a $2,882,080 gain.
HLS
Systems International Limited (OTCBB:HLSYF):
In the quarter ended September 30, 2007, the Fund bought 58,500 shares of common
stock for $498,557.
i2
Telecom International, Inc. (OTCBB:ITUI):
In the quarter ended September 30, 2007, the Fund converted 625 shares of Series
D preferred stock into 3,125,000 shares of common stock. In addition, the Fund
received 802,806 shares of common stock as a dividend on the Series D preferred
stock.
Integrated
Security Systems, Inc.
(OTCBB:IZZI): In the third quarter of 2007, the Fund received 411,375 shares
of
common stock as payment in kind for interest on promissory notes held by the
Fund.
Murdoch
Security and Investigations, Inc.
(Private): In the third quarter of 2007, the Fund paid $500,000 to purchase
1,000,000 shares of common stock and warrants to purchase 1,000,000 shares
of
common stock at $0.70 per share.
Narrowstep,
Inc.
(OTCBB:NRWS): In the third quarter of 2007, the Fund paid $1,000,000 to purchase
4,000,000 shares of common stock and warrants to purchase 2,000,000 shares
of
common stock at $0.50 per share.
PracticeXpert,
Inc. (OTCPK:PXPT):
In the quarter ended September 30, 2007, the Fund sold 4,166,667 shares of
common stock for $4,359, realizing a $495,641 loss.
Shea
Development Corporation
(OTCBB:SDLP): In the third quarter of 2007, the Fund received 401,202 shares
of
common stock related to a reorganization of the company.
Simtek
Corporation
(NASDAQ:SMTK): During the third quarter of 2007, the Fund received options
to
purchase 3,168 shares of common stock at $4.66 per share. The options were
received in connection with Robert C. Pearson’s compensation as a member of
Simtek’s board of directors.
Symbollon
Pharmaceuticals, Inc. (OTCBB:SYMBA):
During the third quarter of 2007, the Fund paid $250,000 to purchase 357,143
shares of common stock and warrants to purchase 357,143 shares of common stock
at $1.00 per share.
Results
of Operations for the Three Months Ended September 30, 2007
For
the
quarter ended September 30, 2007, the Fund had a net investment loss of $166,653
compared to a net investment loss of $83,166 for the third quarter of 2006.
This
change was due in part to a decrease in investment income from $358,288 for
the
third quarter of 2006 to $192,188 for the comparable period of 2007. The
decrease in investment income was primarily attributable to a reduction in
dividend income earned in 2007 and a reduction in interest income earned on
cash
and cash equivalent investments.
Expenses
decreased from $441,454 for the quarter ended September 30, 2006 to $353,841
for
the third quarter of 2007. General and administrative expenses increased for
the
third quarter of 2007 to $91,082 from $63,538 for the third quarter of 2006
primarily due to increases related to shareholder relations expense in 2007.
Legal and professional fees decreased from $140,140 for the third quarter of
2006 to $66,348 in the same period in 2007 as a result of a reduction in legal
and consulting services during the third quarter of 2007. Management fees
decreased from $237,776 for the third quarter of 2006 to $196,411 for the third
quarter of 2007 as a result of a decline in net asset values as of September
30,
2007.
24
The
net
change in unrealized appreciation (depreciation) of investments decreased
$6,259,982 for the quarter ended September 30, 2007 compared to the decrease
of
$2,379,862 for the quarter ended September 30, 2006. This change is primarily
due to declining market values of portfolio investments at the quarter ended
September 30, 2007 as compared to the quarter ended September 30, 2006, and
the
realization of gains or losses upon disposition of investments.
Net
realized gains increased from $874,823 for the quarter ended September 30,
2006
to $2,386,440 for the same period in 2007. The Fund’s investment disposals
during the quarter ended September 30, 2007 resulted in more realized capital
gains than in the corresponding quarter of 2006. This is primarily attributed
to
the realized gain made in the China Security & Surveillance Technology, Inc.
holdings during the quarter ended September 30, 2007.
Results
of Operations for the Nine Months Ended September 30, 2007
For
the
nine months ended September 30, 2007, the Fund experienced net investment loss
in the amount of $599,240, compared to a net investment loss in the amount
of
$890,871 for the same nine-month period in 2006. This change was due in part
to
an increase in investment income from $611,621 for the nine months ended
September 30, 2006 to $645,899 for the comparable period of 2007. This increase
in investment income was primarily attributable to more dividends being earned
in 2007. Dividend income for the nine-month period ended September 30, 2007
was
$386,696 versus $347,037 for the same period in 2006 as a result of dividends
earned on portfolio investments during the nine-month period in 2007.
Expenses
decreased from $1,502,492 for the nine months ended September 30, 2006 to
$1,245,139 for the same period in 2007. General and administrative expenses
increased from $235,777 in the nine months ended September 30, 2006, to $345,792
for the same period in 2007, primarily due to listing fees for the American
Stock Exchange and expenses related to shareholder relations, primarily offset
by a reduction in printing and insurance expenses in 2007. Legal and
professional fees also decreased from $483,288 for the nine months ended
September 30, 2006 to $274,685 for the nine months ended September 30, 2007
as a
result of a reduction in legal and consulting services during the nine months
ended September 30, 2007. Management fees decreased from $723,239 for the nine
months ended September 30, 2006, to $624,662 for the same period in 2007, due
to
a decline in net asset values in 2007.
The
net
change in unrealized appreciation (depreciation) of investments was a decrease
of $7,490,972 for the nine months ended September 30, 2007 compared to
$17,533,952 for the nine months ended September 30, 2006. This change was due
to
market values of portfolio investments at the period end and the realization
of
gains or losses upon disposition of investments.
Net
realized gains decreased from $19,686,060 for the nine months ended September
30, 2006 to $4,420,209 for the same period in 2007. The Fund’s realized
investment transactions during the nine months ended September 30, 2007 resulted
in less realized capital gains than in the corresponding nine-month period
of
2006. This is primarily attributed to the significant realized gain made in
the
disposition of Laserscope holdings during the nine months ended September 30,
2006.
Liquidity
and Capital Resources
Net
assets decreased $3,670,003 during the nine month period from $48,367,442 at
December 31, 2006, to $44,697,439 at September 30, 2007. This decrease is
primarily attributable to the net realized gains being offset by the net
unrealized losses on investments and the net investment loss for the nine-month
period ended September 30, 2007.
At
the
end of the third quarter of 2007, the Fund had cash and cash equivalents of
$5,791,569 versus cash and cash equivalents of $14,835,500 at December 31,
2006.
This decrease is primarily attributable to taxes paid on behalf of stockholders,
cash used for new investments, and payments of certain liabilities. The Fund’s
interest and dividends receivable decreased from $146,146 at December 31, 2006
to $88,197 at September 30, 2007, due primarily to the receipt of interest
payments and the reduction of dividend income on short-term investment balances
during 2007.
25
Accounts
payable decreased from $168,845 at December 31, 2006 to $69,423 at September
30,
2007 primarily due to payments being made during the nine-month period of 2007.
Finally, accounts payable to affiliate decreased from $3,810,462 at December
31,
2006 to $708,443 at September 30, 2007, reflecting the payments of the incentive
fee, and management fees for 2006 payable to the Fund’s investment
adviser.
During
the nine months ended September 30, 2007, the Fund did not declare or pay
dividends to shareholders.
The
majority of the Fund’s investments in portfolio companies are individually
negotiated, non-registered for public trading, and are subject to legal and
contractual investment restrictions. Accordingly, the Fund’s portfolio
investments are generally considered non-liquid. This lack of liquidity
primarily affects the Fund’s ability to make new investments and distributions
to shareholders.
Pending
investment in portfolio investments, funds are invested in temporary cash
accounts and in government securities. Government securities used as cash
equivalents will typically consist of U. S. Treasury securities or other U.
S.
Government and Agency obligations having slightly higher yields and maturity
dates of three months or less. These investments qualify for investment as
permitted in Section 55(a)(1) through (5) of the 1940 Act.
Contractual
Obligations
The
Fund
has a contract for the purchase of services under which it will have future
commitments: the Investment Advisory Agreement, pursuant to which RENN Capital
Group, Inc. has agreed to serve as the Fund’s investment adviser. Such Agreement
has contractual obligations with fees which are based on values of the portfolio
investments which the Fund owns. For further information regarding the Fund’s
obligations under the Investment Advisory Agreement, see Note 4 of the Financial
Statements.
Item
3. Quantitative and Qualitative Disclosure About Market Risk
The
Fund
is subject to financial market risks, including changes in market interest
rates
as well as changes in marketable equity security prices. The Fund does not
use
derivative financial instruments to mitigate any of these risks. The return
on
the Fund’s investments is generally not affected by foreign currency
fluctuations.
A
majority of the Fund’s net assets consists of common stocks and warrants and
options to purchase common stock in publicly traded companies. These investments
are directly exposed to equity price risk, in that a percentage change in these
equity prices would result in a similar percentage change in the fair value
of
these securities.
A
lesser
percentage of the Fund’s net assets consist of fixed rate convertible debentures
and other debt instruments as well as convertible preferred securities. Since
these instruments are generally priced at a fixed rate, changes in market
interest rates do not directly impact interest income, although they could
impact the Fund’s yield on future investments in debt instruments. In addition,
changes in market interest rates are not typically a significant factor in
the
Fund’s determination of fair value of its debt instruments, as it is generally
assumed they will be held to maturity, and their fair values are determined
on
the basis of the terms of the particular instrument and the financial condition
of the issuer.
A
small
percentage of the Fund’s net assets consist of equity investments in private
companies. The Fund would anticipate no impact on these investments from modest
changes in public market equity prices. However, should significant changes
in
market prices occur, there could be a longer-term effect on valuations of
private companies which could affect the carrying value and the amount and
timing of proceeds realized on these investments.
26
Item
4. Controls and Procedures.
The
Fund
has in place systems relating to disclosure controls and procedures (as defined
in Rules 13a-15(e) and 15d-15(e) of the 1934 Act). Our principal executive
officer and principal financial officer evaluated the effectiveness of these
disclosure controls and procedures as of the end of our quarter ended September
30, 2007 in connection with the preparation of this report. They concluded
that
the controls and procedures were effective and adequate at that time. There
were
no significant changes in the Fund’s internal controls over financial reporting
during the third quarter of fiscal 2007 that have materially affected, or are
reasonably likely to materially affect, the Fund’s control over financial
reporting.
27
PART
II. OTHER INFORMATION
Item
1. Legal
Proceedings
No
significant adversarial actions have occurred.
Item
1A. Risk
Factors
You
should carefully consider the risks described below and all other
information contained in this quarterly report on Form 10-Q, including
our
financial statements and the related notes thereto before making
a
decision to purchase our common stock. The risks and uncertainties
described below are not the only ones facing us. Additional risks
and
uncertainties not presently known to us, or not presently deemed
material
by us, may also impair our operations and performance. If any of
the
following risks actually occurs, our business, financial condition
or
results of operations could be materially adversely affected. If
that
happens, the trading price of our common stock could decline, and
you may
lose all or part of your
investment.
|
Our
Growth is Dependent on Investing in Quality Deals.
Sustaining growth depends on our ability to identify, evaluate, finance,
and invest in companies that meet our investment criteria. Accomplishing
such results on a cost-effective basis is a function of our marketing
capabilities and skillful management of the investment process. Failure
to
achieve future growth could have a material adverse effect on our
business, financial condition, and results of
operations.
|
Failure
to Invest Capital Effectively May Decrease Our Stock
Price.
If we fail to invest our capital effectively, our return on equity
may be
decreased, which could reduce the price of the shares of our common
stock.
|
Highly
Competitive Market for Investments.
We compete with a number of private equity funds, other investment
entities and individuals for investment opportunities. Some of these
competitors are substantially larger and have greater financial resources,
and some are subject to different and frequently less stringent
regulation. As a result of this competition, we may not be able to
take
advantage of attractive investment opportunities from time to time,
and
there can be no assurance that we will be able to identify and make
investments that satisfy our
objectives.
|
Lack
of Publicly Available Information on Certain Portfolio
Companies.
Some of the securities in our portfolio are issued by privately held
companies. There is generally little or no publicly available information
about such companies, and we must rely on the diligence of our management
to obtain the information necessary for our decision to invest. There
can
be no assurance that such diligence efforts will uncover all material
information necessary to make fully informed investment
decisions.
|
Dependence
on Key Management.
Selecting, structuring and closing our investments depends upon the
diligence and skill of our management, which is responsible for
identifying, evaluating, negotiating, monitoring and disposing of
our
investments. Our management's capabilities will significantly impact
our
results of operations. If we lose any member of our management team
and
he/she cannot be promptly replaced with an equally capable team member,
our results of operations could be significantly
impacted.
|
Failure
to Meet Listing Standards.
In
May 2007 the Fund was listed on the American Stock Exchange under
the
ticker symbol RCG. Failure to comply with listing standards on a
continuing basis could lead to de-listing, which could impact the
value of
the Fund’s stock.
|
Failure
to Deploy Capital May Lower Returns.
Our failure to successfully deploy sufficient capital may reduce
our
return on equity.
|
Results
May Fluctuate.
Our operating results may fluctuate materially due to a number of
factors
including, among others, variations in and the timing of the recognition
of realized and unrealized gains or losses, the degree to which we
encounter competition in our portfolio companies’ markets, the ability to
find and close suitable investments, and general economic conditions.
As a
result of these factors, results for any period should not be relied
upon
as being indicative of performance in future
periods.
|
28
Uncertain
Value of Certain Restricted Securities.
Our net asset value is based on the values assigned to the various
investments in our portfolio, determined in good faith by our board
of
directors. Because of the inherent uncertainty of the valuation of
portfolio securities which do not have readily ascertainable market
values, our fair value determinations may differ materially from
the
values which would be applicable to unrestricted securities having
a
public market.
|
Illiquid
Securities May Adversely Affect Our Business.
Our portfolio contains securities which are subject to restrictions
on
sale because they were acquired from issuers in "private placement"
transactions or because we are deemed to be an affiliate of the issuer.
Unless an exemption from the registration requirements of the Securities
Act of 1933 is available, we will not be able to sell these securities
publicly without the expense and time required to register the securities
under applicable federal and state securities laws. In addition,
contractual or practical limitations may restrict our ability to
liquidate
our securities in portfolio companies, because we may own a relatively
large percentage of the issuer's outstanding securities. Sales may
also be
limited by unfavorable market conditions. The illiquidity of our
investments may preclude or delay the disposition of such securities,
which may make it difficult for us to obtain cash equal to the value
at
which we record our investments.
|
Regulated
Industry.
Publicly
traded investment funds are highly regulated. Changes in securities
laws
or regulations governing our operations or our failure to comply
with
those laws or regulations may adversely affect our
business.
|
Failure
to Qualify for Favorable Tax Treatment.
We
may not qualify for conduit tax treatment as a Regulated Investment
Company ("RIC") if we are unable to comply with the requirements
of
Subchapter M of the Internal Revenue Code. If we fail to satisfy
such
requirements and cease to qualify for conduit tax treatment, we will
be
subject to federal taxes on our net investment income. The loss of
this
pass-through tax treatment could have a material adverse effect on
the
total return, if any, obtainable from an investment in our common
stock.
|
Highly
Leveraged Portfolio Companies.
Some of our portfolio companies could incur substantial indebtedness
in
relation to their overall capital base. Such indebtedness often has
a term
that will require the balance of the loan to be refinanced when it
matures. If portfolio companies cannot generate adequate cash flow
to meet
the principal and interest payments on their indebtedness, the value
of
our investments could be reduced or eliminated through foreclosure
on the
portfolio company's assets or by the portfolio company's reorganization
or
bankruptcy.
|
Our
Common Stock Often Trades at a Discount.
Our common stock often trades at a discount from net asset value.
Our
common stock is traded over-the-counter in the pink sheets. Stockholders
desiring liquidity may sell their shares at current market value,
which
has often been below net asset value. Shares of closed-end investment
companies frequently trade at discounts from net asset value, which
is a
risk separate and distinct from the risk that a fund's performance
will
cause its net asset value to
decrease.
|
Nature
of Investment in Our Common Stock.
Our stock is intended for investors seeking long-term capital
appreciation. Our investments in portfolio securities generally require
some time to reach maturity, and such investments generally are illiquid.
An investment in our shares should not be considered a complete investment
program. Each prospective purchaser should take into account his
or her
investment objectives as well as his or her other investments when
considering the purchase of our
shares.
|
Our
Stock Price May Fluctuate Significantly.
The market price of our common stock may fluctuate significantly.
The
market price and marketability of shares of our common stock may
from time
to time be significantly affected by numerous factors, including
our
investment results, market conditions, and other influences and events
over which we have no control and that may not be directly related
to
us.
|
29
We
May be Unable to Participate in Certain Investment
Opportunities.
As a
Business Development Company, we are required to invest at least 70% of our
assets directly in Eligible Portfolio Companies. Currently less than 70% of
our
assets are in Eligible Portfolio Companies, and, therefore, we will be unable
to
make new investments in companies that are not considered Eligible Portfolio
Companies until we are above the 70% threshold.
Item
2. Unregistered
Sales of Equity Securities and Use of Proceeds
None
Item
3. Defaults
Upon Senior Securities
None
Item
4. Submission
of Matters to a Vote of Security Holders
None
Item
5. Other
Information
None.
Item
6. Exhibits
31.1 |
Certification
of the principal executive officer pursuant to Section 302 of the
Sarbanes-Oxley Act of 2002
|
31.2 |
Certification
of the principal financial officer pursuant to Section 302 of the
Sarbanes-Oxley Act of 2002
|
32.1 |
Certification
of the principal executive officer pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002
|
32.2 |
Certification
of the principal financial officer pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002
|
30
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Fund has duly
caused this report to be signed on its behalf by the undersigned hereunto duly
authorized.
RENAISSANCE
CAPITAL GROWTH & INCOME FUND III, INC.
|
|||
/s/ Russell Cleveland | November 13, 2007 | ||
Russell
Cleveland, President and CEO
(Principal
Executive Officer)
|
/s/ Barbe Butschek | November 13, 2007 | ||
Barbe
Butschek, Chief Financial Officer
(Principal
Financial Officer)
|
31